There’s hope that Health Canada’s approval of Pfizer’s antiviral COVID-19 treatment will help ease the strain on the country’s health-care system, as hospitalizations continue their steady climb. The pill uses a combination of two antiviral drugs to prevent the virus that causes COVID-19 from replicating once it has infected a patient, but...
Read Full StoryIf the content contained herein violates any of your rights, including those of copyright, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com
comments